| 製品番号 |
製品名 |
製品効果
|
純度 |
Rare Diseases
|
| HY-156650 |
Votoplam |
Modulator |
99.51% |
Unkown |
| HY-16009 |
Buntanetap |
|
99.71% |
Unkown |
| HY-132579A |
Tominersen sodium |
|
97.36% |
Unkown |
| HY-136780 |
SEN177 |
Inhibitor |
98.76% |
Unkown |
| HY-156103 |
mHTT-IN-2 |
Inhibitor |
99.35% |
Unkown |
| HY-177360 |
Ruxuplam |
Inhibitor |
99.08% |
Unkown |
| HY-132593A |
Rovanersen sodium |
|
95.58% |
Unkown |
| HY-160884 |
DMT-2'-OMe-D-Ribitol phosphoramidite |
|
99.23% |
Unkown |
| HY-16009B |
Buntanetap L-Tartrate |
|
98.93% |
Unkown |
| HY-143792 |
HTT-D3 |
|
/ |
Unkown |
| HY-150236 |
FITC-labeled Tominersen sodium |
Inhibitor |
97.65% |
Unkown |
| HY-10542A |
(Z)-GW 5074 |
Inhibitor |
/ |
Unkown |
| HY-175136 |
Chloroguanabenz acetate |
Agonist |
/ |
Unkown |
| HY-184480 |
PROTAC HTT Degrader-1 |
Degrader |
/ |
Unkown |
| HY-184481 |
DHPT-PEG2-C2-NH2 |
Ligand |
/ |
Unkown |
| HY-D3112 |
P2-Aggregate |
|
/ |
Unkown |
| HY-P10822 |
ED11 |
Inhibitor |
/ |
Unkown |
| HY-RS06490 |
HTT Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS13311 |
SLC6A4 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS13312 |
Slc6a4 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W792458 |
MADAM |
Ligand |
/ |
Unkown |
| HY-RS18021 |
Htt Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS24494 |
Htt Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |